Patient Resources
Action Plans
This section contains the customizable action plans for patients with different tumor types that have been customized for the Canadian audience.
Pembrolizumab
- Bladder (Urothelial) Cancer
- Hodgkin Lymphoma, Classical
- Lung Cancer, Non-Small Cell
- Melanoma
- MSI-H/dMMR, Other Solid Tumors
Nivolumab
- Head and Neck Squamous Cell Carcinoma
- Hodgkin Lymphoma, Classical
- Kidney Cancer (Renal Cell Carcinoma)
- Liver Cancer (Hepatocellular Carcinoma)
- Lung Cancer, Non-Small Cell
- Melanoma